Registry study for advanced pancreatic cancer treatment patterns
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This registry collects information about people with advanced pancreatic cancer who are receiving first-line palliative treatment. It helps doctors understand which treatment choices are used and how people do over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old
- You have been diagnosed with pancreatic ductal adenocarcinoma confirmed by pathology (a tissue/pathology test)
- Your cancer is advanced (locally advanced that can’t be removed and/or has spread to other places)
- You are starting or receiving palliative first-line treatment with chemotherapy (like a platinum-based or gemcitabine-based regimen)
- Your health status is good enough for daily activities (ECOG score 0 to 2)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is a research registry that collects information from adults with suspected or diagnosed pancreatic cancer. It may help doctors better understand the disease and improve care over time.
This trial tests treatments that are chosen specifically for you based on the genetic makeup of your tumor. The goal is to find a targeted therapy that may work better for your advanced pancreatic cancer after standard chemotherapy has stopped being effective.
This trial studies metastatic pancreatic cancer by taking a small tissue sample and analyzing its genes. It may help doctors better understand which cancer subtypes patients have, which can guide future treatment choices.
This study collects information from people diagnosed with pancreatic cancer. It aims to improve care by learning from your medical records.
This study collects health information and stored samples (biospecimens) to learn more about pancreatic diseases, including cancer and early warning changes. It may help researchers understand who is at higher risk and improve future testing and care.
This study collects medical information from people with gastrointestinal (GI) cancer, both those treated in the past and those currently receiving care. The goal is to learn more about the disease and improve future treatments.
Hear when a new Pancreatic cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.